Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases.
$18.35-0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+11.8%
The outlook
Odyssey Therapeutics, Inc. currently reads as bullish based on strong buy — 1.2 avg of 3 analysts, above its 50- & 200-day averages, 63% of the way from its 52-week low to high, avg target +74% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.2 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Price targetAvg target +74% vs current price
Analyst price target
~12-month · 3 analysts$32.00average target+74.4% vs now
Now $18.35
Low $26.00High $40.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$881.4M
52-wk high
$20.30
52-wk low
$15.10
50-day avg
$17.51
200-day avg
$17.50
Trailing P/E
—